Show simple item record

dc.contributor.authorSasson, David
dc.contributor.authorSánchez Fernández, Iván
dc.contributor.authorIlligens, Ben M. W.
dc.contributor.authorSauer, Christopher
dc.contributor.authorPaik, Kenneth
dc.contributor.authorMcCague, Ned J
dc.contributor.authorCeli, Leo Anthony G.
dc.date.accessioned2019-03-07T16:03:02Z
dc.date.available2019-03-07T16:03:02Z
dc.date.issued2018-11
dc.date.submitted2018-05
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/1721.1/120798
dc.description.abstractBackground: Tuberculosis is a major cause of morbidity and mortality in the developing world. Drug resistance, which is predicted to rise in many countries worldwide, threatens tuberculosis treatment and control. Objective: To identify features associated with treatment failure and to predict which patients are at highest risk of treatment failure. Methods: On a multi-country dataset managed by the National Institute of Allergy and Infectious Diseases we applied various machine learning techniques to identify factors statistically associated with treatment failure and to predict treatment failure based on baseline demographic and clinical characteristics alone. Results: The complete-case analysis database consisted of 587 patients (68% males) with a median (p25-p75) age of 40 (30–51) years. Treatment failure occurred in approximately one fourth of the patients. The features most associated with treatment failure were patterns of drug sensitivity, imaging findings, findings in the microscopy Ziehl-Nielsen stain, education status, and employment status. The most predictive model was forward stepwise selection (AUC: 0.74), although most models performed at or above AUC 0.7. A sensitivity analysis using the 643 original patients filling the missing values with multiple imputation showed similar predictive features and generally increased predictive performance. Conclusion: Machine learning can help to identify patients at higher risk of treatment failure. Closer monitoring of these patients may decrease treatment failure rates and prevent emergence of antibiotic resistance. The use of inexpensive basic demographic and clinical features makes this approach attractive in low and middle-income countries.en_US
dc.publisherPublic Library of Scienceen_US
dc.relation.isversionofhttp://dx.doi.org/10.1371/journal.pone.0207491en_US
dc.rightsCreative Commons Attribution 4.0 International licenseen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourcePLoSen_US
dc.titleFeature selection and prediction of treatment failure in tuberculosisen_US
dc.typeArticleen_US
dc.identifier.citationSauer, Christopher Martin, David Sasson, Kenneth E. Paik, Ned McCague, Leo Anthony Celi, Iván Sánchez Fernández, and Ben M. W. Illigens. “Feature Selection and Prediction of Treatment Failure in Tuberculosis.” Edited by Zhengxing Huang. PLOS ONE 13, no. 11 (November 20, 2018): e0207491. © 2018 Sauer et al.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Scienceen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.mitauthorSauer, Christopher
dc.contributor.mitauthorPaik, Kenneth
dc.contributor.mitauthorMcCague, Ned J
dc.contributor.mitauthorCeli, Leo Anthony G.
dc.relation.journalPLOS ONEen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2019-03-07T15:52:19Z
dspace.orderedauthorsSauer, Christopher Martin; Sasson, David; Paik, Kenneth E.; McCague, Ned; Celi, Leo Anthony; Sánchez Fernández, Iván; Illigens, Ben M. W.en_US
dspace.embargo.termsNen_US
mit.licensePUBLISHER_CCen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record